{
    "elements": [
        {
            "type": "table",
            "sequence_num": 1,
            "data": {
                "num_rows": 16,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MAJOR HAEMORRHAGE MANAGEMENT"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "13012"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Clinical Staff Portering Staff Transport Staff"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "31 March 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "30 March 2023"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Haemorrhage, bleed, blood, loss, major, massive"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "National Guidance/Recommendations: BSH guidelines, NICE guidelines"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9,10,11,12,15,17,19"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "MSE Group services, Pathology, Mid Essex"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Transfusion Practitioner"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Hospital Transfusion Group"
                    },
                    {
                        "text": "31 January 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Kevin Beaton Dr Niven Akotia"
                    },
                    {
                        "text": "Medical Director Consultant Anaesthetist and Hospital Transfusion Group Lead"
                    },
                    {
                        "text": "31 January 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "26 March 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "April 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 41,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Nagi"
                    },
                    {
                        "text": "Consultant Haematologist with responsibility for transfusion"
                    },
                    {
                        "text": "31 January 2020"
                    },
                    {
                        "text": "Dr Laura Harding"
                    },
                    {
                        "text": "Surgical Divisional Director"
                    },
                    {
                        "text": "Dr Matt Sweeting"
                    },
                    {
                        "text": "Divisional Director Medicine and Emergency Care"
                    },
                    {
                        "text": "Dr Alex Hieatt"
                    },
                    {
                        "text": "Trauma Lead"
                    },
                    {
                        "text": "Wendy Matthews"
                    },
                    {
                        "text": "Director of Nursing"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Women's and Childrens Divisional Director"
                    },
                    {
                        "text": "Roslyn Bullen-Bell"
                    },
                    {
                        "text": "Associate Director of Nursing \u2013 Women and Children"
                    },
                    {
                        "text": "Teresa Nicholas"
                    },
                    {
                        "text": "Blood Bank Manager"
                    },
                    {
                        "text": "Eileen Caples"
                    },
                    {
                        "text": "Senior Biomedical Scientist for Coagulation"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "Maria Richards"
                    },
                    {
                        "text": "Principle Clinical Pharmacist \u2013 Emergency care"
                    },
                    {
                        "text": "Helen Clarke"
                    },
                    {
                        "text": "Governance Lead"
                    },
                    {
                        "text": "Samantha Goldberg"
                    },
                    {
                        "text": "Director of Operations"
                    },
                    {
                        "text": "James Day"
                    },
                    {
                        "text": "Trust Secretary"
                    },
                    {
                        "text": "Ian Edwards"
                    },
                    {
                        "text": "Matron of Resus Training, Trigger Response and Hospital Out Of Hours"
                    },
                    {
                        "text": "Hilary Bowring"
                    },
                    {
                        "text": "Associate Director of Nursing"
                    },
                    {
                        "text": "Nick Archer"
                    },
                    {
                        "text": "Matron for Theatres"
                    },
                    {
                        "text": "Jo Clayden"
                    },
                    {
                        "text": "Stroke and Neurology Matron"
                    },
                    {
                        "text": "Rebecca Summerskill"
                    },
                    {
                        "text": "Matron Emergency Medicine"
                    },
                    {
                        "text": "Ruth Byford"
                    },
                    {
                        "text": "Warner Library"
                    },
                    {
                        "text": "14 February 2020"
                    },
                    {
                        "text": "Dr Waseem Nagi"
                    },
                    {
                        "text": "Consultant Haematologist with responsibility for transfusion"
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "Dr Niven Akotia"
                    },
                    {
                        "text": "Consultant Anaesthetist and HTG lead"
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "Dr Alex Hieatt"
                    },
                    {
                        "text": "Trauma Lead"
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "Dr James Klewe"
                    },
                    {
                        "text": "Consultant in Emergency Medicine"
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "Teresa Nicholas"
                    },
                    {
                        "text": "Blood Bank Manager"
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Hospital Transfusion Group"
                    },
                    {
                        "text": "31 January 2020"
                    },
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Standard Infection Prevention 04071 Manual of Blood transfusion Policies and Procedures Blood Transfusion Policy 04184 Policy for the use of Medicines 08081 Major Incident Plan 060125 Management of postpartum haemorrhage 04234 Serious incident requiring investigation policy 11025 Transport of Blood, Blood Products in an Obstetric Emergency 07024 Patient Identification Policy MSEPO-21002"
                    },
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Holden"
                    },
                    {
                        "text": "New Policy"
                    },
                    {
                        "text": "01 April 2013"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Sheppard"
                    },
                    {
                        "text": "Updated to cover massive blood loss in all adults instead of trauma only and inclusion of children."
                    },
                    {
                        "text": "01 January 2014"
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "N Sheppard"
                    },
                    {
                        "text": "Appendix 1 updated"
                    },
                    {
                        "text": "01 September 2014"
                    },
                    {
                        "text": "1.3"
                    },
                    {
                        "text": "N Sheppard"
                    },
                    {
                        "text": "Reviewed this guideline following release of BCSH guideline \u2018A Practical Guideline for the Management of those with, or at risk of Major Haemorrhage'"
                    },
                    {
                        "text": "20 December 2015"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Sheppard"
                    },
                    {
                        "text": "Policy review"
                    },
                    {
                        "text": "20 February 2015"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Updated MHP activation protocols as per EoE RTC"
                    },
                    {
                        "text": "10 July 2018"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Policy review"
                    },
                    {
                        "text": "31 March 2020"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": "Dr N Akotia, Dr Hieatt, T Parker"
                    },
                    {
                        "text": "Policy into MSE Trust format and update to 6.27 and 6.28 the word Trauma added. Update to PCC, removal of methylene blue components. Referral to identification policy MSEPO-21002"
                    },
                    {
                        "text": "17 September 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 9,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 5,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 6,
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Introduction .................................................................................................................. 4  Scope ........................................................................................................................... 4  Abbreviations .............................................................................................................. 5  Roles and responsibilities ............................................................................................ 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The purpose of this manual is to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "Provide guidance for staff actively involved in the transfusion pathway and the management of major haemorrhage;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "Provide staff with information of how to activate the protocol;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "text": "Enable the Trust to meet the standards required by:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Correctly used, blood and blood products can save lives and provide clinical benefit  to patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The consequences to the patient of receiving incompatible blood may be serious"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "text": "and include, shock due to intravascular haemolysis, cessation of renal blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "text": "circulation and death. This is recognised as a never event, and largely preventable   if the following recommendations are always followed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "The consequences of mistakes made during the collection of blood samples for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "text": "transfusion work may be serious. Whilst a compatible transfusion may help to save   a patient's life, an incompatible transfusion may kill."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This document is intended to provide information for all Trust staff involved in the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "text": "transfusion management of a patient with major haemorrhage within trauma, surgery and medicine. This refers to both adult and paediatric patients (Adults please see appendix 2, Children please see appendix 4)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "Maternity Services are excluded from scope as they have their own stand-alone clinical guideline for dealing with major haemorrhage. (Refer to the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "text": "guideline entitled \u2018Emergency transport of blood specimens in the event of a major   haemorrhage' (07024); and guideline entitled \u2018Management of postpartum"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "text": "haemorrhage (04234)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "text": "2.3. Following guidance, the Hospital Transfusion Group meets to co-ordinate the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "text": "varying interests of all parties involved in the transfusion process and procedures   to ensure the safe and appropriate use of blood and blood products."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Abbreviations"
            }
        },
        {
            "type": "table",
            "sequence_num": 27,
            "data": {
                "num_rows": 17,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "APTT"
                    },
                    {
                        "text": "Activated Partial Throbmoplastin Time"
                    },
                    {
                        "text": "BSH"
                    },
                    {
                        "text": "British Standards in Haematology"
                    },
                    {
                        "text": "DIC"
                    },
                    {
                        "text": "Disseminated Intravascular Coagulation (DIC)"
                    },
                    {
                        "text": "DOAC"
                    },
                    {
                        "text": "Direct Oral Anti-Coagulants"
                    },
                    {
                        "text": "FBC"
                    },
                    {
                        "text": "Full Blood Count"
                    },
                    {
                        "text": "GMP"
                    },
                    {
                        "text": "Good Manufacturing Practice"
                    },
                    {
                        "text": "HTG"
                    },
                    {
                        "text": "Hospital Transfusion Group"
                    },
                    {
                        "text": "HTT"
                    },
                    {
                        "text": "Hospital Transfusion Team"
                    },
                    {
                        "text": "MHP"
                    },
                    {
                        "text": "Major Haemorrhage Protocol"
                    },
                    {
                        "text": "NHSBT"
                    },
                    {
                        "text": "NHS Blood and Transplant service"
                    },
                    {
                        "text": "PCC"
                    },
                    {
                        "text": "Human Prothombin Complex Concentrate - Beriplex"
                    },
                    {
                        "text": "PT"
                    },
                    {
                        "text": "Prothombin Time"
                    },
                    {
                        "text": "Q-pulse"
                    },
                    {
                        "text": "Laboratory quality management system"
                    },
                    {
                        "text": "SABRE"
                    },
                    {
                        "text": "Serious Adverse Blood Reactions and Events body"
                    },
                    {
                        "text": "SaBTO"
                    },
                    {
                        "text": "Safety of Blood, Tissues and Organs"
                    },
                    {
                        "text": "SHOT"
                    },
                    {
                        "text": "Serious Hazards of Transfusion: reporting body"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Role & Responsibilities within the Hospital Transfusion Group"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "The Hospital Transfusion Group (HTG) is responsible for monitoring and reviewing   blood transfusion practice throughout the Trust for the safe and appropriate use of   blood products and for agreeing changes in practice to improve its safety and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "efficacy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "This also includes reviewing National and local policies, local protocols and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "practices for requesting and obtaining blood in both routine and emergency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "situations (including out of hours). To ensure that they include all the actions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "required by clinical teams, laboratories and support services, e.g. portering and   transport staff/drivers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Role & Responsibilities of Hospital Transfusion Team within the Trust:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "text": "The Hospital Transfusion Team (HTT) is responsible for ensuring that all"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "aspects of transfusion practice are audited, and that where necessary appropriate   corrective actions implemented and reported to the HTG."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The HTT has the responsibility of ensuring any deviations to the Major"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Haemorrhage policy are reported via Q-pulse (the laboratory quality management   system), Datixweb ( the Trust incident reporting system), and/or SHOT and SABRE   as appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "Role & Responsibilities of individuals within the Trust:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "Laboratory Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "The Laboratory Management must ensure all laboratory staff involved in the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "blood transfusion process are adequately trained. This includes yearly training   and competency assessment in duties associated with the issuing of blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "products, including taking requests for blood, recording information provided"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "and Good Manufacturing Practice (GMP) training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "The Blood Transfusion Laboratory Staff"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "text": "Blood Transfusion Laboratory staff are responsible for ensuring that blood products/components are made available at the request of medical staff in"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "accordance with this policy. Staff must ensure that blood components are suitable for the relevant patient as identified on the supplied pre transfusion blood sample and that safe working practices are adhered to."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Staff taking blood samples"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Staff taking blood samples (e.g. phlebotomy) for pre transfusion testing are"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "responsible for ensuring that the identity of the patient from whom the sample is obtained is clearly and accurately written on the blood sample label and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "associated forms and that all necessary patient information is provided. Patient information must be taken from the patient's identification band and verbally"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "confirmed with the patient (wherever possible). The person taking the blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "samples as one uninterrupted process, to avoid errors, must label blood sample bottles \u2018by hand' at the patient's side. Addressograph labels must never be"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "The Major Haemorrhage Team"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 1,
                "text": "The Major Haemorrhage Team consists of Anaesthetists, Medical and Surgical"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "Clinicians, Paediatricians (where appropriate), Porters and Operating Department Practitioners (where appropriate). Laboratory staff are included in being part of the MH Team but would not be expected to attend the department where the Major"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "Haemorrhage is taking place."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "All staff involved in blood transfusion practice are responsible for ensuring that they update their knowledge, are conversant with current Trust policies and   procedures, have successfully completed relevant training and are authorised to   undertake these duties."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 4.11,
                "text": "Individual members of staff must ensure they are aware of their responsibilities   and the key role they play in the delivery of a safe and effective blood   transfusion service."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 4.12,
                "text": "The Clinician in charge of the case, the Team Leader, will designate the appropriate   staff member to be able to co-ordinate the line of communication between the   Blood Transfusion Department and the clinical team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "prefix": 4.13,
                "text": "The Team Leader may be a Consultant or the Middle Grade in Emergency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "Medicine, Anaesthetist or Consultant in another Specialty."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 4.14,
                "text": "The Team Leader will delegate tasks to the members of the team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 4.15,
                "text": "All staff members involved must have current valid transfusion training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Definition of Major haemorrhage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Definition of Major Haemorrhage:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 70.0,
                "text": "Loss of more than one blood volume within 24 hours (around 70 mL/kg, >5 litres in a  kg adult)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "50% of total blood volume lost in less than 3 hours"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "Bleeding in excess of 150 mL/minute."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "A pragmatic clinically based definition is bleeding which leads to a systolic blood pressure of less than 90 mm Hg or a heart rate of more than 110 beats per minute"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Red cell transfusion is usually necessary if 30\u201340% blood volume is lost, and rapid   loss of >40% is immediately life threatening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Peripheral blood haematocrit and Hb concentration may be misleading early after   major acute blood loss and the initial diagnosis of major haemorrhage requiring   transfusion should be based on clinical criteria and observations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "For immediate transfusion, group O red cells should be issued after samples are   taken for blood grouping and crossmatching."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Females less than 55 years of age should receive D negative red cells to avoid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "sensitisation. The use of Kell negative red cells is also desirable in this group. Group   O red cells must continue to be issued if patient or sample identification is"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "incomplete or until the ABO group is confirmed on a second sample according to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "MEHT policy. However this should not delay blood transfusion in the emergency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "situation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "If the patient is pregnant laboratory staff must be informed in order that"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "cytomegalovirus (CMV) negative blood is issued as per current SaBTO guidelines."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": ". Major Haemorrhage (MH)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The Team Leader (often the most senior doctor directing resuscitation of the patient)   and coordinators are responsible for communicating with laboratories and other   support services."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "The Team Leader can co-ordinate management of the team to prevent time-wasting   and confusing duplicate calls between departments."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Dial 2222 state \u201cActivate Major Haemorrhage Protocol ward XXXXX\u201d"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "The switchboard staff can play a key role in initial alert of key staff followed by"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "contact of further teams as needed as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "Porter/other support staff;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Senior clinician depending on clinical area;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "Anaesthetist;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "Intensive Therapy Unit;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "Senior nurse/midwife;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Transfusion laboratory;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "Other laboratories (Haematology and Coagulation, Biochemistry);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "Clinical Haematologist on call;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "Radiology including interventional radiology."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "In an emergency situation it is essential to ensure correct transfusion identification   procedures for patients, samples and blood components are performed and an   accurate record is kept of all blood components transfused."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "If the patient is unknown, a unique identifier should be allocated to each individual"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "patient. If more than one unknown patient is admitted at the same time, each needs  to be given a unique identifier and unique number. This aims to prevent confusion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "when samples are sent to the laboratory and other tests are requested for the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "different patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 6.7,
                "text": "Refer to appendix 2 for the algorithm of major haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 1,
                "prefix": 6.8,
                "text": "Adult trauma patients with, or at risk of, major haemorrhage, in whom"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "antifibrinolytics are not contraindicated, should be given tranexamic acid as soon as   possible after injury, at a dose of 1 gram intravenously over  min followed by a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "maintenance infusion of 1 g over 8 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Paediatric trauma patients may also benefit from early use of tranexamic acid. An   initial dose of 15 mg/kg (maximum  mg) intravenously over  min given as   soon as possible and within 3 hours of trauma is recommended, followed by   2 mg/kg/h for at least 8 h or until the bleeding stops."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Maintain normothermia as this is one of the simplest and most effective methods of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "minimizing blood loss once the primary source has been controlled."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 6.11,
                "text": "Red cells and fresh frozen plasma given for MH must pass through a blood warmer   whenever possible. Platelet function becomes markedly impaired if body"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "text": "temperature drops to 35\u00b0C and therefore increases the risk of disseminated"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "intravascular coagulation (DIC). When transfusing red cells >50ml/kg/hr, the use of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "text": "an approved blood warmer or rapid infusion device is recommended."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "prefix": 70.0,
                "text": "Red cell transfusion is usually necessary if 30\u201340% blood volume is lost (1500 ml in   a \u2010kg male), and rapid loss of >40% (1500\u20132000 ml) is immediately   life threatening."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 6.13,
                "text": "Maintain tissue perfusion and oxygenation. This is critical in preventing the   development of hypovolemic shock and consequent multi-organ failure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 6.14,
                "text": "The risk of clerical error increases in the emergency setting and meticulous attention   must be given to ensuring that the correct patient is given the correct blood or blood   product."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "prefix": 6.15,
                "text": "Accurate documentation of blood and blood components given and the reason for transfusion is a legal requirement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 6.16,
                "text": "The blood unit labels from the packs must be returned to the Blood Transfusion Department for tracking following the procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 6.17,
                "text": "Every patient must wear an identification band (wristband), and there must be in"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "place a robust system for identification of the unconscious patient. (See MSEPO \u2013"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "21002/1.0)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 6.18,
                "text": "Refer to Trust policies for infection control to ensure that the infection control   measures in place are followed throughout the procedure (Trust Policy 04071)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 6.19,
                "text": "The guidance below relates to adults and children. For children and neonates the   doses/volumes used are based on the child's weight and blood loss. Please see   Appendix 4 for further information."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Major acute haemorrhage requiring massive transfusion produces major tissue   injury from circulatory failure, which leads to tissue hypoxia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "prefix": 6.21,
                "text": "The aim of treatment is to minimise the period of tissue hypoxia by rapidly restoring   circulating volume and controlling haemorrhage. Emergency surgery may be   required to achieve this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 6.22,
                "text": "For patients with active bleeding use a restrictive approach to volume resuscitation   until definitive early control of bleeding has been achieved."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "prefix": 6.23,
                "text": "In pre-hospital settings, titrate volume resuscitation to maintain a palpable central   pulse (carotid or femoral)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "prefix": 6.24,
                "text": "In hospital settings, move rapidly to haemorrhage control, titrating volume   resuscitation to maintain central circulation until control is achieved."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "prefix": 6.25,
                "text": "For patients who have haemorrhagic shock and a traumatic brain injury:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "If haemorrhagic shock is the dominant condition, continue restrictive volume"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "text": "resuscitation or;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "If traumatic brain injury is the dominant condition, use a less restrictive volume   resuscitation approach to maintain cerebral perfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 6.26,
                "text": "Fluid replacement in pre\u2010hospital and hospital settings:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "prefix": 6.27,
                "text": "In Trauma patients in the pre-hospital settings only use crystalloids to replace fluid   volume in patients with active bleeding if blood components are not available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 6.28,
                "text": "In hospital settings do not use crystalloids for trauma patients with active bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "text": "See the section on resuscitation in the NICE guideline 'Intravenous fluid therapy in   adults in hospital' and the section on fluid resuscitation in the NICE guideline"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "'Intravenous fluid therapy in children and young people in hospital' for advice on"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "tetrastarches."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "prefix": 6.29,
                "text": "For adults (16 or over) use a ratio of 1 unit of plasma to 1 unit of red blood cells to   replace fluid volume."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "For children (under 16's) use a ratio of 1 part plasma to 1 part red blood cells, and   base the volume on the child's weight."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "prefix": 6.31,
                "text": "Haemorrhage protocols in hospital settings"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 6.32,
                "text": "Hospital trusts should have specific major haemorrhage protocols for adults (16 or   over) and children (under 16s)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 6.33,
                "text": "For patients with active bleeding, start with a fixed\u2010ratio protocol for blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "text": "components and change to a protocol guided by laboratory coagulation results at   the earliest opportunity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "prefix": 6.34,
                "text": "The first stage in the management of major acute haemorrhage is the rapid infusion   of 1 to 2 litres of Hartmann's solution or colloid (Gelofusin). Core cooling is a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "problem with rapid transfusion and these solutions should be kept at 37\u00baC. Venous   access should be bylarge bore cannulae and a blood sample for cross-match"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "should be drawn at the time of insertion, correctly labelled and sent directly to the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "prefix": 6.35,
                "text": "Assess the effects of the fluid challenge and decide upon the type of transfusion required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 6.36,
                "text": "If the patient is stable, wait for laboratory test results (45 to 60 minutes)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "prefix": 6.37,
                "text": "MH packs of blood/blood products will be requested and issued in the event of   major blood loss as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "MH Primary Pack:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "red cell units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "4 fresh frozen plasma (FFP) units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "MH Secondary Pack:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "red cell units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "4 fresh frozen plasma (FFP) units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "1 unit of platelets"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "2 units of cryoprecipitate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "prefix": 6.38,
                "text": "Be aware FFP can take 20-25 minutes to defrost, inform blood transfusion   laboratory staff of the need for FFP at the earliest opportunity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 6.39,
                "text": "If the situation is not stable, request type specific blood (ABO and D typing only). The requirement for O D negative blood is extremely rare. Remember these units may be incompatible if the patient has red cell antibodies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "A dedicated appropriate person should call the blood transfusion department in consultation with the leader of the event, ask for either \u2018Major haemorrhage \u2013 Pack 1' (primary pack) or \u2018Major haemorrhage \u2013 Pack 2' (secondary pack)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "prefix": 6.41,
                "text": "It is sometimes of benefit to the situation to have two major haemorrhage primary Pack 1 packs before using the major haemorrhage secondary Pack 2."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "prefix": 6.42,
                "text": "Consider the use of cell salvage to reduce the requirement for banked blood."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "prefix": 6.43,
                "text": "Cell salvage can produce a rapid supply of red cells, with 250 ml of washed salvaged red cells considered to be equivalent to one unit of packed red cells. It can be particularly useful in managing haemorrhage associated with open aortic aneurysm repair, splenic and liver trauma, pelvic and femoral fractures, abdominal and thoracic trauma and haemorrhage at caesarean section."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "prefix": 72.0,
                "text": "If the patient is pregnant, consider anti D for those with D negative blood groups. It needs to be administered within  hours of any potentially sensitising events (PSE)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "prefix": 6.45,
                "text": "Patients on anticoagulation (e.g. warfarin, acenocoumarol, phenindione"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "text": "DOACs), and patients on antiplatelet drugs may require specific haemostatic   measures, e.g. PCC, or platelet transfusion. Discuss with on call Consultant   Haematologist via switchboard."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "prefix": 6.46,
                "text": "For patients on anticoagulants or antiplatelet drugs, consider the use of other coagulation factor concentrates such as factor VIIa (this will require Consultant Haematologist authorisation)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "prefix": 6.47,
                "text": "The coagulopathy of bleeding is related to loss of blood, consumption of coagulation factors, activation of fibrinolysis and haemodilution by resuscitation fluids."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "prefix": 6.48,
                "text": "Developing hypothermia, acidosis and hypocalcaemia will further worsen coagulation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "prefix": 6.49,
                "text": "It is important to monitor haemostatic changes to guide the use of blood components after initial resuscitation, with coagulation and platelet testing performed every 30\u201360 min, depending on the severity of blood loss, until bleeding ceases."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "There is a need for rapid turnaround times for coagulation tests in a major haemorrhage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "prefix": 6.51,
                "text": "Shock increases endothelial damage which itself leads to a consumption of coagulation factors and platelets. This is further aggravated by dilution."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "prefix": 6.52,
                "text": "The requirement for fresh frozen plasma, cryoprecipitate and platelets will be based on the coagulation and full blood count results possibly in consultation with the Haematologist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "prefix": 6.53,
                "text": "Where there is pre-existing liver and renal disease, anticoagulation or aspirin ingestion, requirements for these coagulation factors and platelets will be accelerated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "prefix": 6.54,
                "text": "Following prolonged haemorrhage in the presence of continued oozing from"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 0,
                "text": "multiple sites at surgery, consideration should be given to the use of tranexamic   acid."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 0,
                "prefix": 6.55,
                "text": "Consider arterial blood gas measurement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 0,
                "prefix": 6.56,
                "text": "O D negative red blood cells for the use in an emergency situation are located in"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 0,
                "text": "the following places:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "Broomfield Hospital:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 0,
                "text": "2 units in the Pathology reception ward blood bank"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "text": "2 units and 1 unit suitable for neonatal use in Labour Ward's blood bank"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 0,
                "text": "Braintree Community Hospital:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 0,
                "text": "2 units based in Courtauld ward blood bank"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 188,
            "data": {
                "is_heading": 0,
                "prefix": 6.57,
                "text": "The risks and benefits of transfusion must be discussed with the patient where possible. Appropriate consent must be given in accordance with Trust policy and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "documented within the patient's medical records. In the unconscious patient,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "text": "treatment is given in the patient's best interests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 0,
                "prefix": 6.58,
                "text": "Major haemorrhage in trauma indicates extremis, and invariably the patient is"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 0,
                "text": "unable to give consent. In the case of an identified Jehovah's Witness, (in absence   of advanced directive) the views of the family will be taken into account where"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "possible but the decision to transfuse rests with the clinician responsible for the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 0,
                "prefix": 6.59,
                "text": "The early use of platelets should be considered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 196,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "Portering staff will need to be contacted to divert them to attend the blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 0,
                "text": "transfusion laboratory to collect blood components, if it is deemed to be a Major Haemorrhage requiring immediate transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "The components:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Red Cells: are necessary for their oxygen\u2010carrying capacity, and also contribute to   improved haemostasis through rheological effect leading to axial flow, and thus   margination of platelets and plasma."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Fully crossmatched red cell units \u2013 issued within 45 minutes of a valid G&S sample"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 1,
                "text": "reaching the laboratory. Note: At any time, requests for fully crossmatched blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 0,
                "text": "can be converted to group specific units by contacting the blood transfusion laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "ABO-group-specific red cells can usually be issued within  minutes of a sample   arriving in the laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Red cell transfusion is likely to be required when >30 \u2013 40% of blood volume is lost.   It is important to note that blood loss is usually underestimated and that Hb and Hct   values do not fall for several hours after acute haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Although recognised as the universal donor, group O D negative emergency units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 0,
                "text": "of red cells (Flying Squad blood) may not be suitable for transfusion where the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 0,
                "text": "patient has red cell antibodies. Where patients are known to have red cell"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "text": "antibodies and time allows, seek the advice of the Blood Transfusion Department /   Consultant Haematologist-On-Call prior to using these units."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "Initial resuscitation of patients with massive gastrointestinal haemorrhage should   include transfusion of red cells, platelets and clotting factors according to the local   major haemorrhage protocol. In patients who are actively bleeding, the platelet"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "count should be maintained >50\u00d710/L, PT ratio >1.5 and fibrinogen >1.5 g/L."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "Platelets"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Platelet counts should not fall below  x10/L in acutely bleeding patients or trauma   patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 0,
                "prefix": 7.9,
                "text": "One unit of group A D negative platelets are routinely kept in stock at Broomfield"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "text": "Hospital. However, check with the blood bank if platelets are immediately available,   and if they are not they will be requested from the NHSBT on ad hoc basis, if"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 0,
                "text": "needed, and can take up to 1.5 hours to be delivered. In extreme emergency, they   can be ordered on a \u201cblue light\u201d to expedite very urgent delivery, but this will have to   be made clear to laboratory staff when requesting platelets. A blue light request has   to be authorised by the requesting clinician."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 216,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "The normal dose is 1 adult therapeutic dose (ATD) but 2 ATD may be indicated for   patients with platelet count <30x10/L."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Platelet count <50x10/L may be anticipated after 1.5 \u2013 2 x blood volume   replacement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 0,
                "prefix": 7.12,
                "text": "It is advisable to pre-empt platelet units for patients with massive blood loss when   levels are above the target value to ensure their availability when needed and to   enable replacement stock to be ordered in a timely manner."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "The platelet count usually remains above 50\u00d710/L (the generally accepted   haemostatic level) until 1.5 to 2.5 blood volumes have been replaced."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 220,
            "data": {
                "is_heading": 0,
                "prefix": 7.14,
                "text": "Fresh Frozen Plasma (FFP)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 0,
                "prefix": 7.15,
                "text": "FFP should be transfused in doses of 12\u201315 mL/kg (at least four units in the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 0,
                "text": "average adult) to maintain the PT ratio (compared to \u2018normal pooled plasma') less   than 1.5. Fibrinogen levels should be maintained above 1.5 g/L."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 1,
                "prefix": 7.16,
                "text": "FFP can be used to correct coagulopathy in patients with acute massive blood loss.   It is important to assess the degree of coagulopathy to ensure adequate   replacement is provided."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 0,
                "prefix": 7.17,
                "text": "Thawing FFP takes approximately 20-25 minutes and it is therefore important to   forward plan when treating acute massive blood loss."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 225,
            "data": {
                "is_heading": 0,
                "prefix": 7.18,
                "text": "Coagulopathy may be anticipated after 1.5 times blood volume replacement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 0,
                "text": "Therefore, samples to assess coagulopathy must be taken at regular intervals if   bleeding persists."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 0,
                "prefix": 7.19,
                "text": "Once bleeding is under control, further FFP should be guided by abnormalities in   laboratory tests with transfusion trigger of PT and/or APTT >1\u00b75 times normal for a   standard dose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 228,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "If laboratory results are not available, and bleeding continues, further FFP may be   transfused."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 0,
                "prefix": 7.21,
                "text": "Use of FFP should not delay fibrinogen supplementation if it is required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 0,
                "prefix": 7.22,
                "text": "Cryoprecipitate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 0,
                "prefix": 7.23,
                "text": "Fibrinogen supplementation should be given if fibrinogen levels fall below 1\u00b75 g/l."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 0,
                "prefix": 7.24,
                "text": "Cryoprecipitate is the standard source of fibrinogen in the UK and two five\u2010donor   pools will increase fibrinogen in an adult by approximately 1 g/l."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 0,
                "prefix": 7.25,
                "text": "Cryoprecipitate is indicated for patients whose fibrinogen is low and to aim for   fibrinogen of >1.5g/l."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 0,
                "prefix": 7.26,
                "text": "The standard adult dose is 2 packs which takes approximately 20-25 minutes to   thaw and issue and therefore it is important to forward plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 0,
                "prefix": 7.27,
                "text": "When thawed, cryoprecipitate is stored at ambient temperature and must not be   kept in the fridge prior to transfusion. It must be used within 4 hours of thawing."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 0,
                "prefix": 7.28,
                "text": "Human Prothombin Complex Concentrate (PCC, Beriplex)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 0,
                "prefix": 7.29,
                "text": "These are licensed pharmaceutical products Usually issued to reverse a high INR   in patients on warfarin who are experiencing a haemorrhagic episode (See   Beriplex \u00ae P/N intravenous infusion)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Indicated for the treatment and perioperative prophylaxis of bleeding in acquired   deficiency of the prothrombin complex coagulation factors such as deficiency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 0,
                "text": "caused by the treatment with vitamin K antagonists or in case of overdose of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "vitamin K antagonists, when rapid correction of the deficiency is required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 0,
                "prefix": 7.31,
                "text": "Prothrombin Complex Concentrate, PCC: Factor II, VII, IX and X concentrate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "The main indication is warfarin overdose where there is life-threatening bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 0,
                "prefix": 7.32,
                "text": "PCC is recommended product that should be used for warfarin reversal, not FFP.   It may be used in patients with haemorrhage, particularly where there is a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 244,
            "data": {
                "is_heading": 0,
                "text": "contraindication to the use of FFP, and head injury with suspected intracerebral"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 0,
                "text": "haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 0,
                "prefix": 7.33,
                "text": "Consider immediate prothrombin complex concentrate transfusions to reverse"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 247,
            "data": {
                "is_heading": 0,
                "text": "warfarin anticoagulation in patients having emergency surgery, depending on the   level of anticoagulation and the bleeding risk."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 248,
            "data": {
                "is_heading": 0,
                "prefix": 7.34,
                "text": "In non-emergency situations Beriplex can be issued without discussion with the   Consultant Haematologist if the request meets the following criteria:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 249,
            "data": {
                "is_heading": 0,
                "prefix": 7.35,
                "text": "In the emergency situation an emergency dose of 1000iu of Beriplex is available"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 250,
            "data": {
                "is_heading": 0,
                "text": "from the blood transfusion department. Provide the patient's name (unique name as   applicable) DOB and hospital number (unique number as applicable) to laboratory"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 251,
            "data": {
                "is_heading": 0,
                "text": "staff. This can be available to collect as soon as details given and this request has   been made. Send a porter to attend to collect it from the blood transfusion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 252,
            "data": {
                "is_heading": 0,
                "text": "department."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 253,
            "data": {
                "is_heading": 0,
                "prefix": 7.36,
                "text": "PCC and intravenous vitamin K should be used if immediate warfarin reversal is   needed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 254,
            "data": {
                "is_heading": 0,
                "prefix": 7.37,
                "text": "The INR must be checked again 1 hour after the administration of PCC. Vitamin K   should be given at the same time as PCC."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 255,
            "data": {
                "is_heading": 0,
                "prefix": 7.38,
                "text": "Patients should be informed that Beriplex is derived from human plasma in case   they refuse for example for religious reasons."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 256,
            "data": {
                "is_heading": 0,
                "prefix": 7.39,
                "text": "Beriplex is issued in 500iu doses. Each box contains one dry powder vial one vial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 257,
            "data": {
                "is_heading": 0,
                "text": "containing water for injections and one \u2018mix2vial\u00ae'. This allows the medication to be   mixed together with no need for a needle, therefore reducing the risk of needle stick   injury."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 258,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Reconsitution:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 259,
            "data": {
                "is_heading": 0,
                "text": "Remove the lids from the two ampoules and the mix2vial\u00ae . Wipe clean using   aseptic wipe. Place the water ampule (blue lid) on the hard surface, place the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 260,
            "data": {
                "is_heading": 0,
                "text": "carton containing the mix2vial l \u00ae over it, and press firmly. Take the container off the mix2vial\u00ae  leaving the device in the top of the water ampoule, place the ampoule containing the powder onto the hard surface. Lift the water ampoule"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 261,
            "data": {
                "is_heading": 0,
                "text": "complete with the mix2vial\u00ae in place and press firmly into the ampoule containing   the powder. Once the water has drawn down into the mixture fully, swirl the water   and powder together gently. Twist the top section off the mix2vial\u00ae  and use a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 262,
            "data": {
                "is_heading": 0,
                "text": "syringe to drawer up the medication."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 263,
            "data": {
                "is_heading": 0,
                "prefix": 7.41,
                "text": "Do not dilute or mix Beriplex with any other product. It must be reconstituted on a   Hard flat surface."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 264,
            "data": {
                "is_heading": 0,
                "prefix": 7.42,
                "text": "Administer at approx. 8mls per minute and can be given by slow IV push or via a   syringe driver."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 265,
            "data": {
                "is_heading": 0,
                "prefix": 7.43,
                "text": "Recombinant activated Factor VII (rFVIIa):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 266,
            "data": {
                "is_heading": 0,
                "text": "NovoSeven (eptacog alfa (activated)) is only released following Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 267,
            "data": {
                "is_heading": 0,
                "text": "Haematologist approval. It is recombinant activated human coagulation Factor Vll"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 268,
            "data": {
                "is_heading": 0,
                "text": "(rVlla). It was developed for the treatment of congenital and acquired haemophilia A   and B with antibodies against Factors Vlll and lX and is licensed for this purpose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 269,
            "data": {
                "is_heading": 0,
                "prefix": 7.44,
                "text": "NovoSeven induces haemostasis at the site of tissue injury by forming complexes   with exposed tissue factor, and by directly activating Factor X on the surface of   activated platelets thereby potentiating the \u2018thrombin burst'."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 270,
            "data": {
                "is_heading": 0,
                "prefix": 7.45,
                "text": "NovoSeven has a short half-life of around 2 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 271,
            "data": {
                "is_heading": 0,
                "prefix": 7.46,
                "text": "More recently NovoSeven has been used in the treatment of catastrophic"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 272,
            "data": {
                "is_heading": 0,
                "text": "haemorrhage unresponsive to fresh frozen plasma (FFP)/cryoprecipitate/platelets   or surgical treatment. It is not licensed for this indication."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 273,
            "data": {
                "is_heading": 0,
                "prefix": 7.47,
                "text": "Indications for use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 274,
            "data": {
                "is_heading": 0,
                "text": "NovoSeven should be considered in the management of massive ongoing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 275,
            "data": {
                "is_heading": 0,
                "text": "haemorrhage not responding to the standard measures including adequate blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 276,
            "data": {
                "is_heading": 0,
                "text": "product support with fresh frozen plasma, cryoprecipitate and platelet concentrations   to maintain :"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 277,
            "data": {
                "is_heading": 0,
                "text": "Prothombin time (PT) and activated partial thrombin time (APPT) ratios"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 278,
            "data": {
                "is_heading": 0,
                "text": "Fibrinogen > 1.5g/L"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 279,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Platelet count >  x 10/L"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 280,
            "data": {
                "is_heading": 0,
                "text": "(It is acknowledged that these parameters may not be achieved in catastrophic   haemorrhage)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 281,
            "data": {
                "is_heading": 0,
                "prefix": 7.48,
                "text": "The use of NovoSeven should be considered before proceeding to hysterectomy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 282,
            "data": {
                "is_heading": 0,
                "prefix": 7.49,
                "text": "Dose and administration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 283,
            "data": {
                "is_heading": 0,
                "text": "NovoSeven is supplied in vials of 1mg and is kept in the transfusion laboratory"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 284,
            "data": {
                "is_heading": 0,
                "text": "The recommended dose is 90\u03bcg/kg \u2013 e.g. 6mg for a 70kg woman"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 285,
            "data": {
                "is_heading": 0,
                "text": "Full instructions for reconstitution and administration are supplied on the package insert, and the administration is the responsibility of ward staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 286,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "For optimal efficiency, the platelet count must be > 50 x 10/L"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 287,
            "data": {
                "is_heading": 0,
                "text": "A further dose of NovoSeven should be considered at 2 hours \u2013 especially if   haemorrhage continues"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 288,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Monitoring: The coagulation screen and FBC should be repeated 2 \u2013 4 hourly, and   after administration of blood components to monitor response as directed by the   Consultant Haematologist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 289,
            "data": {
                "is_heading": 0,
                "prefix": 7.51,
                "text": "Blood component therapy should be continued according to the results of the   coagulation tests."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 290,
            "data": {
                "is_heading": 0,
                "prefix": 7.52,
                "text": "Fast-track of blood samples: In cases of acute Major Haemorrhage, it is vital to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 291,
            "data": {
                "is_heading": 0,
                "text": "ensure that FBC and coagulation samples are processed quickly to ensure that a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 292,
            "data": {
                "is_heading": 0,
                "text": "timely assessment of coagulopathy, haemoglobin and platelet count can be made"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 293,
            "data": {
                "is_heading": 0,
                "text": "and appropriate blood components issued. However, do not delay the administration of blood components by waiting for results of these tests in the major Haemorrhage situation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 294,
            "data": {
                "is_heading": 0,
                "prefix": 7.53,
                "text": "Once acute major blood loss is identified the Blood Transfusion laboratory should be alerted. Communicate very clearly that blood is required in an emergency."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 295,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Paediatric/Neonatal patients"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 296,
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "The standard definitions of neonates (up to  days of postnatal age) and infants   (>28 days to <1 year) are used. The definition of a child is <18 years, but in many   cases children are admitted to adult wards from  years of age."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 297,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Within the first 4 months, wherever possible, samples from both mother and infant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 298,
            "data": {
                "is_heading": 0,
                "text": "should be obtained for initial ABO and D group determination. The antibody screen   should be undertaken on the maternal sample when available. A maternal sample is   preferred for antibody testing for the following reasons:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 299,
            "data": {
                "is_heading": 0,
                "text": "If maternal antibody has bound to fetal cells in vivo, the resulting lower concentration of antibody in neonatal plasma could lead to a false negative antibody screen result."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 300,
            "data": {
                "is_heading": 0,
                "text": "It is easier to obtain a sufficiently large sample from the mother to allow for screening and antibody identification if required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 301,
            "data": {
                "is_heading": 0,
                "text": "Sample collection from the infant exacerbates the anaemia of prematurity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 302,
            "data": {
                "is_heading": 0,
                "text": "The maternal sample should be collected within 3 day pre\u2010delivery or collected"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 303,
            "data": {
                "is_heading": 0,
                "text": "post\u2010delivery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 304,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Major Haemorrhage related to trauma is uncommon in children. Major bleeding is   more common in the surgical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 305,
            "data": {
                "is_heading": 0,
                "prefix": 90.0,
                "text": "The total blood volume in children ranges from  ml/kg in term infants down to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 306,
            "data": {
                "is_heading": 0,
                "text": "70\u201380 ml/kg in later childhood/adolescence. For simplicity, a figure of 80 ml/kg could   reasonably be applied for all children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 307,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Major Haemorrhage in children may be defined as either 80 ml/kg in  hours,   40 ml/kg in 3 hours or 2\u20133 ml/kg/min."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 308,
            "data": {
                "is_heading": 0,
                "prefix": 8.6,
                "text": "In clinical practice, haemodynamic changes compatible with hypovolaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 309,
            "data": {
                "is_heading": 0,
                "text": "accompanying evidence or suspicion of serious haemorrhage are the usual triggers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 310,
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "Appropriate transfusion of fetal and paediatric patients of all ages is vital in order to   balance transfusion benefits against risks. These risks include transfusion of an"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 311,
            "data": {
                "is_heading": 0,
                "text": "incorrect blood component due to errors, such as mistaken patient identity, or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 312,
            "data": {
                "is_heading": 0,
                "text": "unpredictable acute transfusion reactions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 313,
            "data": {
                "is_heading": 0,
                "prefix": 8.8,
                "text": "Specialised components are available for transfusion to different paediatric patient   groups and for different clinical indications."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 314,
            "data": {
                "is_heading": 0,
                "prefix": 8.9,
                "text": "Additional component safety measures are applied for fetal and neonatal patients,   who are particularly vulnerable recipients because of their small size and   developmental immaturity and who also have the longest potential lifespan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 315,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Thresholds for transfusion are typically based on the haemoglobin concentration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 316,
            "data": {
                "is_heading": 0,
                "text": "platelet count and/or coagulation screen results .These are surrogates for clinical   transfusion need (and coagulation ranges in neonates are particularly difficult to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 317,
            "data": {
                "is_heading": 0,
                "text": "interpret) but in most cases are the most pragmatic solution until there is evidence   for better clinical measures."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 318,
            "data": {
                "is_heading": 0,
                "prefix": 8.11,
                "text": "Key principles in Paediatric Major Haemorrhage are:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 319,
            "data": {
                "is_heading": 0,
                "text": "Early recognition of children at risk of MH using clinical parameters"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 320,
            "data": {
                "is_heading": 0,
                "text": "Education of staff to understand when to activate/trigger the local major haemorrhage protocol and to seek specialist assistance as appropriate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 321,
            "data": {
                "is_heading": 0,
                "text": "Active resuscitation and control of bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 322,
            "data": {
                "is_heading": 0,
                "text": "Seek specialist assistance (with paediatric expertise)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 323,
            "data": {
                "is_heading": 0,
                "text": "Rapid provision of O D\u2010negative or group\u2010specific red cells"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 324,
            "data": {
                "is_heading": 0,
                "text": "Prescribe all transfused components in ml/kg bodyweight (for children <50 kg) and not as units."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 325,
            "data": {
                "is_heading": 0,
                "text": "Anticipate and treat coagulopathy and thrombocytopenia in trauma with early use of FFP and consideration of platelets and cryoprecipitate in on\u2010going bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 326,
            "data": {
                "is_heading": 0,
                "text": "Use tranexamic acid in trauma"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 327,
            "data": {
                "is_heading": 0,
                "text": "Avoid hypothermia, hypocalcaemia, acidosis and hyperkalaemia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 328,
            "data": {
                "is_heading": 0,
                "text": "Because unit sizes vary for children, the recommended component ratios should be pragmatically given on a volume basis rather than as units."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 329,
            "data": {
                "is_heading": 0,
                "text": "Initial immediate transfusion of 20 ml/kg RBCs should be given (up to four adult"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 330,
            "data": {
                "is_heading": 0,
                "text": "units), O D\u2010negative or ABO and D\u2010specific."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 331,
            "data": {
                "is_heading": 0,
                "prefix": 8.12,
                "text": "Send blood samples \u2013 crossmatch, FBC, PT / APTT / Fibrinogen, Biochemistry   (U&E, LFT, ionised Ca, phosphate) Arterial / venous blood gas measurement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 332,
            "data": {
                "is_heading": 0,
                "prefix": 8.13,
                "text": "Resuscitate: IV fluids \u2013 crystalloid or colloid \u2013 10\u201320ml/kg. Give oxygen."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 333,
            "data": {
                "is_heading": 1,
                "prefix": 8.14,
                "text": "Blood loss >40% blood volume (i.e. >30ml/kg) is immediately life-threatening"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 334,
            "data": {
                "is_heading": 0,
                "text": "Give Group O D negative if immediate need and/or blood group unknown."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 335,
            "data": {
                "is_heading": 0,
                "text": "The blood transfusion lab will provide group specific/cross matched red cells as   required"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 336,
            "data": {
                "is_heading": 0,
                "prefix": 8.15,
                "text": "Prevent coagulopathy:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 337,
            "data": {
                "is_heading": 0,
                "text": "Anticipate need for platelets and FFP after 20\u201330ml/kg blood replacement and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 338,
            "data": {
                "is_heading": 0,
                "text": "continuing bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 339,
            "data": {
                "is_heading": 0,
                "text": "Give Primary Children's Major Haemorrhage (C-MH) Pack"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 340,
            "data": {
                "is_heading": 0,
                "text": "Order Secondary Children's Major Haemorrhage (C-MH) Pack (Secondary pack to be given if bleeding continues)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 341,
            "data": {
                "is_heading": 0,
                "text": "Correct hypothermia and use fluid warmer"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 342,
            "data": {
                "is_heading": 0,
                "text": "Correct hypocalcaemia (keep ionised Ca>1 mmol/L)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 343,
            "data": {
                "is_heading": 1,
                "text": "Contact Haematologist"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 344,
            "data": {
                "is_heading": 0,
                "prefix": 8.16,
                "text": "Maintain stability: Repeat blood gas (including Hb, ionised Ca, Na, K, glucose)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 345,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "every  minutes. Repeat FBC, coagulation after every 40ml/kg blood components   given. Monitor HR, BP, capillary refill, saturation, temperature, urine output"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 346,
            "data": {
                "is_heading": 1,
                "prefix": 8.17,
                "text": "Primary C-MH pack"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 347,
            "data": {
                "is_heading": 0,
                "text": "Blood 30ml/kg (up to 5 units)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 348,
            "data": {
                "is_heading": 0,
                "text": "FFP 15-30ml/kg FFP (up to 4 units)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 349,
            "data": {
                "is_heading": 0,
                "text": "Aim for Trauma: RBC: FFP 1:1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 350,
            "data": {
                "is_heading": 0,
                "text": "Other Major Haemorrhage RBC: FFP 2:1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 351,
            "data": {
                "is_heading": 0,
                "text": "Give platelets if over 40mls/kg of red cells given"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 352,
            "data": {
                "is_heading": 1,
                "prefix": 8.18,
                "text": "Secondary C-MH pack"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 353,
            "data": {
                "is_heading": 0,
                "text": "Blood 30ml/kg (up to 5 units)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 354,
            "data": {
                "is_heading": 0,
                "text": "FFP 15-30ml/kg (up to 4 units)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 355,
            "data": {
                "is_heading": 0,
                "text": "Platelets 15ml/kg (up to 1 unit)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 356,
            "data": {
                "is_heading": 0,
                "text": "Cryoprecipitate 10ml/kg up to 2 pools (300ml)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 357,
            "data": {
                "is_heading": 0,
                "prefix": 8.19,
                "text": "Platelets and cryoprecipitate must be considered if active bleeding persists after   initial resuscitation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 358,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Early use of tranexamic acid has been shown to reduce mortality in adult trauma"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 359,
            "data": {
                "is_heading": 0,
                "text": "and this beneficial effect may also apply in children. An initial dose of 15 mg/kg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 360,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "(maximum 1000 mg) intravenously over  min given as soon as possible and within   2 hours of trauma, followed by 2 mg/kg/h over 8 hours or until the bleeding stops."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 361,
            "data": {
                "is_heading": 0,
                "prefix": 8.21,
                "text": "In order to prevent over\u2010transfusion of blood components, all prescriptions should be   ordered and prescribed in millilitres rather than units. The maximum prescribed   volume should not be greater than the volume for equivalent adult transfusions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 362,
            "data": {
                "is_heading": 0,
                "prefix": 8.22,
                "text": "For children whose parents refuse to consent to transfusion, for example Jehovah's   witnesses, a full and timely discussion between the consultant and the family is   crucial."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 363,
            "data": {
                "is_heading": 0,
                "prefix": 8.23,
                "text": "Where blood components may be administered in order to save life, despite parental   refusal or refusal of the child, individual cases should always be discussed with   the Trust's legal department where possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 364,
            "data": {
                "is_heading": 0,
                "prefix": 8.24,
                "text": "In emergency situations it may not be possible to meet all the standard"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 365,
            "data": {
                "is_heading": 0,
                "text": "neonatal/paediatric specifications and the risks of delays in transfusion have to be"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 366,
            "data": {
                "is_heading": 0,
                "text": "balanced against the risk of using components of alternative specification. This includes the use of D\u2010negative units for babies of mothers with non\u2010D antibodies (e.g. anti\u2010c/cE)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 367,
            "data": {
                "is_heading": 0,
                "prefix": 8.25,
                "text": "Intrauterine Transfusions (IUT) are invasive procedures with a risk of fetal death of   1\u20133% per procedure and up to 20% for hydropic fetuses, depending on the   underlying aetiology of the anaemia. IUTs are only undertaken in specialized fetal   medicine units with the requisite interventional skills and expertise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 368,
            "data": {
                "is_heading": 1,
                "prefix": 8.26,
                "text": "Neonates"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 369,
            "data": {
                "is_heading": 0,
                "text": "Transfusion triggers for neonates will vary depending on the clinical context,   including the gestational age at birth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 370,
            "data": {
                "is_heading": 0,
                "prefix": 8.78,
                "text": "Neonatal transfusion guidelines have generally been developed as a result of   neonatal studies predominantly of very low birth weight (VLBW; <1\u00b75 kg) babies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 371,
            "data": {
                "is_heading": 0,
                "prefix": 8.28,
                "text": "In neonatal intensive care units (NICUs) most transfusions are given to preterm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 372,
            "data": {
                "is_heading": 0,
                "text": "neonates (mostly <32 weeks gestational age, some of whom will require transfusion   beyond 28 days of life)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 373,
            "data": {
                "is_heading": 0,
                "prefix": 8.29,
                "text": "In general, babies of all gestational and postnatal ages on NICUs will tend to be   transfused using the same guidelines although there is little evidence specifically   related to term babies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 374,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "For situations of major haemorrhage in neonates, it seems reasonable to apply the   principles of the management of major bleeding in children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 375,
            "data": {
                "is_heading": 0,
                "prefix": 8.31,
                "text": "There is a risk of hyperkalaemia following large volume transfusions, particularly if"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 376,
            "data": {
                "is_heading": 0,
                "text": "infused rapidly. Therefore it is recommended that red cells for large volume neonatal   and infant transfusion are used before the end of day 5 following donation (and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 377,
            "data": {
                "is_heading": 0,
                "text": "within 24 h of irradiation) in order to reduce this risk in the recipient. However, this"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 378,
            "data": {
                "is_heading": 0,
                "text": "should not delay transfusion if this criteria cannot be met."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 379,
            "data": {
                "is_heading": 0,
                "prefix": 8.32,
                "text": "Rapid transfusion via a central line may represent a particular risk, and the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 380,
            "data": {
                "is_heading": 0,
                "prefix": 23.0,
                "text": "alternative use of large bore (greater than  g) peripheral lines in small babies may   not always be technically feasible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 381,
            "data": {
                "is_heading": 0,
                "prefix": 8.33,
                "text": "Serum electrolyte concentrations should be monitored frequently, including calcium   (to prevent hypocalcaemia secondary to citrate overload) and potassium."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 382,
            "data": {
                "is_heading": 0,
                "prefix": 8.34,
                "text": "All large volume transfusions should be given via a blood warmer to avoid the   development of hypothermia. Core temperature should be monitored, as   recommended for adults."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 383,
            "data": {
                "is_heading": 0,
                "prefix": 8.35,
                "text": "Neonatal platelet transfusions: The use of platelet transfusions for neonates with   Thrombocytopenia and active bleeding is considered appropriate, but there is"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 384,
            "data": {
                "is_heading": 0,
                "text": "uncertainty and practice variation in the wider use of platelet transfusions for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 385,
            "data": {
                "is_heading": 0,
                "text": "prophylaxis in the absence of bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 386,
            "data": {
                "is_heading": 0,
                "prefix": 8.36,
                "text": "In the absence of results from randomised control trials (RCTs) in this patient group, recommendations for prophylactic platelet transfusion are made on the basis of clinical experience."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 387,
            "data": {
                "is_heading": 0,
                "prefix": 8.37,
                "text": "While these may also apply to term neonates (e.g. those admitted to paediatric"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 388,
            "data": {
                "is_heading": 0,
                "text": "intensive care units (PICUs)), many pediatrician's might consider more liberal use   of platelets in unstable preterm neonates and more restrictive use in stable term   infants."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 389,
            "data": {
                "is_heading": 0,
                "prefix": 8.38,
                "text": "FFP may be of benefit in neonates with clinically significant bleeding or prior to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 390,
            "data": {
                "is_heading": 0,
                "text": "invasive procedures with a risk of significant bleeding, and who have an abnormal   coagulation profile, defined as a PT or APTT significantly above the normal"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 391,
            "data": {
                "is_heading": 0,
                "text": "gestational and postnatal age\u2010related reference range."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 392,
            "data": {
                "is_heading": 0,
                "prefix": 8.39,
                "text": "Overall, the management of low fibrinogen is the same in neonates as in children.   Severe congenital hypofibrinogenaemia may present in the neonatal period but   neonatal hypofibrinogenaemia is most likely to be acquired, secondary to DIC or   liver dysfunction."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 393,
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "Cryoprecipitate may also be indicated in neonatal cardiac surgery and major   haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 394,
            "data": {
                "is_heading": 0,
                "prefix": 8.41,
                "text": "Vitamin K deficiency bleeding, (VKDB) may occur and require urgent treatment if"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 395,
            "data": {
                "is_heading": 0,
                "text": "major bleeding occurs in neonates or children. Four factor prothrombin complex"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 396,
            "data": {
                "is_heading": 0,
                "text": "concentrate (PCC) is preferable to FFP, although there is little published data on this   indication. Vitamin K is recommended for every newborn infant, and bleeding may"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 397,
            "data": {
                "is_heading": 0,
                "text": "occur after missed prophylaxis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 398,
            "data": {
                "is_heading": 0,
                "prefix": 8.42,
                "text": "Tranexamic acid should be considered in all children undergoing surgery where   there is risk of significant bleeding 15mg/kg bolus up to a maximum of 1g."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 399,
            "data": {
                "is_heading": 0,
                "prefix": 8.43,
                "text": "Red cell salvage should be considered in all children at risk of significant bleeding   undergoing surgery and where transfusion may be required, providing there are   appropriately trained staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 400,
            "data": {
                "is_heading": 0,
                "prefix": 8.44,
                "text": "Given a lack of studies in paediatrics, recommendations for platelet transfusions in   critically ill children or those with haematological/oncological malignancies who"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 401,
            "data": {
                "is_heading": 0,
                "text": "develop severe thrombocytopenia are drawn from the wider adult literature and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 402,
            "data": {
                "is_heading": 0,
                "text": "recommendations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 403,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Practical guidance: It is suggested that for most stable children prophylactic platelet   transfusions should be administered when the platelet count is below  \u00d7 10/l,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 404,
            "data": {
                "is_heading": 0,
                "text": "excluding patients with immune thrombocytopenia, thrombotic thrombocytopenic"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 405,
            "data": {
                "is_heading": 0,
                "text": "purpura/haemolytic uraemic syndrome and heparin\u2010induced thrombocytopenia who   should only be transfused with platelets for life\u2010threatening bleeding. Seek"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 406,
            "data": {
                "is_heading": 0,
                "text": "Haematology Consultant advice in these instances."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 407,
            "data": {
                "is_heading": 0,
                "prefix": 8.46,
                "text": "FFP and cryoprecipitate may be administered either therapeutically"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 408,
            "data": {
                "is_heading": 0,
                "text": "for the management of bleeding or prophylactically. There is very little evidence of   benefit from FFP administration in many settings where it is currently used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 409,
            "data": {
                "is_heading": 0,
                "prefix": 8.47,
                "text": "The major indications for cryoprecipitate transfusion in infants and children are DIC   with bleeding, bleeding following cardiac surgery and major haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 410,
            "data": {
                "is_heading": 0,
                "prefix": 8.48,
                "text": "Fibrinogen threshold levels of 1\u00b70 g/l are recommended for inherited"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 411,
            "data": {
                "is_heading": 0,
                "text": "hypofibrinogenaemia but where there is rapid consumption e.g. in DIC or major   haemorrhage, higher target thresholds for therapy may be recommended."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 412,
            "data": {
                "is_heading": 0,
                "prefix": 8.49,
                "text": "Transfuse FFP volumes of 15\u201320 ml/kg, using the higher volumes in bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 413,
            "data": {
                "is_heading": 0,
                "text": "patients, and ensure monitoring of clinical outcome. However, care should be taken   to avoid volume overload, particularly in vulnerable patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 414,
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "Transfuse cryoprecipitate volumes of 5\u201310 ml/kg, using the higher volumes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 415,
            "data": {
                "is_heading": 0,
                "text": "particularly in bleeding patients, and ensure monitoring of clinical outcome and   fibrinogen levels."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 416,
            "data": {
                "is_heading": 0,
                "prefix": 8.51,
                "text": "FFP may be beneficial in children with DIC who have a significant coagulopathy   (PT/APTT >1\u00b75 times midpoint of normal range or fibrinogen <1\u00b70 g/l) associated   with clinically significant bleeding or prior to invasive procedures."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 417,
            "data": {
                "is_heading": 0,
                "prefix": 8.52,
                "text": "Cryoprecipitate may be given if the fibrinogen is <1\u00b70g/l despite FFP, or in   conjunction with FFP for very low or rapidly falling fibrinogen."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 418,
            "data": {
                "is_heading": 0,
                "prefix": 8.53,
                "text": "Suspect 40% blood loss if significant source of bleeding suspected and clinical   parameters as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 419,
            "data": {
                "is_heading": 0,
                "text": "Age Heart rate Systolic BP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 420,
            "data": {
                "is_heading": 0,
                "text": ">160"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 421,
            "data": {
                "is_heading": 0,
                "text": "1\u20132 years >150"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 422,
            "data": {
                "is_heading": 0,
                "text": "3\u20135 years >140"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 423,
            "data": {
                "is_heading": 0,
                "text": "6\u201312 years >120"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 424,
            "data": {
                "is_heading": 0,
                "text": ">12 years >100"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 425,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Coagulation and Major Haemorrhage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 426,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The transfusion of large volumes of red cells and other intravenous fluids that   contain no coagulation factors or platelets causes dilutional coagulopathy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 427,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Major traumatic haemorrhage is often associated with activation of the coagulation   and fibrinolytic systems (\u2018acute traumatic coagulopathy')."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 428,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "Plasma fibrinogen predictably falls to sub-haemostatic levels (<1.5 g/L) after 1 to 1.5   blood volume replacement (earlier in the presence of coagulopathy and   hyperfibrinolysis)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 429,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Coagulation is also impaired by hypothermia, acidosis and reduced ionised calcium   (Ca2+) concentration (which can be measured on many blood gas analysers)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 430,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "Ionised hypocalcaemia may be caused by rapid transfusion of blood components containing citrate anticoagulant, although this is uncommon in the presence of normal liver function."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 431,
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Traditional \u2018massive transfusion' guidelines use laboratory tests such as prothrombin   time (PT) and activated partial thromboplastin time (APTT)and fibrinogen levels to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 432,
            "data": {
                "is_heading": 0,
                "text": "guide blood component replacement. The usefulness of these tests is reduced by"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 433,
            "data": {
                "is_heading": 0,
                "text": "the significant delay between sampling and returning results to the clinical team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 434,
            "data": {
                "is_heading": 0,
                "prefix": 9.7,
                "text": "If a PT can be made available with a rapid turnaround time that allows it to reflect   the clinical situation it can be used to aid decisions regarding FFP infusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 435,
            "data": {
                "is_heading": 0,
                "text": "However, this should not delay FFP transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 436,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Blood samples should be sent to the laboratory at the earliest opportunity for blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 437,
            "data": {
                "is_heading": 0,
                "text": "grouping and compatibility testing."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 438,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Blood samples should be sent to the laboratory for baseline haematology,   coagulation screen (including fibrinogen estimation) and biochemistry   investigations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 439,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Where possible, without delaying treatment, these samples should be taken prior to   administration of blood components."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 440,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "It is important to check parameters frequently to monitor the need for and efficacy of   the component therapy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 441,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Near patient testing devices can offer a rapid guide to component therapy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 442,
            "data": {
                "is_heading": 0,
                "prefix": 10.6,
                "text": "Haematology Consultant advice may be sought regarding further laboratory   investigations, their interpretation and optimum corrective therapy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 443,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Should the blood be required from the laboratory before cross-matching has been completed, the units can only be issued as un-crossmatched (group specific) on the authority of the medical officer directly in charge of the case."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 444,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "If red cell units are required immediately, request type specific blood (ABO and D typing only). This can be issued on receipt of the cross match blood sample after determining the patient's blood group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 445,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "The requirement for O (D) negative blood is extremely rare. Emergency O"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 446,
            "data": {
                "is_heading": 0,
                "text": "(D) negative red cell units are available in the ward blood bank in pathology"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 447,
            "data": {
                "is_heading": 0,
                "text": "reception (and Labour Ward) and can be collected when required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 448,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "O (D) negative blood units may not be suitable for use if patients are known to have   red cell antibodies. Where it is known that a patient has a red cell antibody, and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 449,
            "data": {
                "is_heading": 0,
                "text": "time allows, seek the advice of the Blood Transfusion Department or Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 450,
            "data": {
                "is_heading": 0,
                "text": "Haematologist on call. However, where need is life threatening, do not delay"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 451,
            "data": {
                "is_heading": 0,
                "text": "transfusion. It is possible that the Blood Transfusion Department may be able to issue an alternative unit for this group of patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 452,
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "If the Rh (D) negative blood is taken, inform the Blood Transfusion Department   immediately so they can be replaced."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 453,
            "data": {
                "is_heading": 0,
                "prefix": 11.6,
                "text": "In some cases it is possible to issue blood units electronically, if the patient fulfils"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 454,
            "data": {
                "is_heading": 0,
                "text": "the criteria for electronically issued blood. In cases such as this, blood units can be   made available within 5 minutes of the request."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 455,
            "data": {
                "is_heading": 0,
                "prefix": 11.7,
                "text": "Blood may be issued electronically (computer issued) if"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 456,
            "data": {
                "is_heading": 0,
                "text": "The patient has two identical groups on samples collected on different occasions;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 457,
            "data": {
                "is_heading": 0,
                "text": "A negative red cell antibody screen on both samples;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 458,
            "data": {
                "is_heading": 0,
                "text": "Electronic testing and transfer of results;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 459,
            "data": {
                "is_heading": 0,
                "text": "No previous history of antibodies being detected;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 460,
            "data": {
                "is_heading": 0,
                "text": "There is a current valid sample (laboratory will advise)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 461,
            "data": {
                "is_heading": 0,
                "prefix": 45.0,
                "text": "If red cell units have to be compatibility tested then the process will take approximately  minutes from receipt of the sample in the Blood Transfusion Department."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 462,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Early, effective and timely communication between clinicians and Blood Transfusion   Laboratory staff is essential."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 463,
            "data": {
                "is_heading": 1,
                "prefix": 12.2,
                "text": "The Major Haemorrhage protocol can be activated by dialling 2222 and saying \u2018Major Haemorrhage, Zone XXX, Zone X, Ward XXXX'. The switchboard operator will activate the Major Haemorrhage Protocol. This will initialise the MH Team. The Blood Transfusion Department must then be contacted directly Monday to Friday \u2013 09:00hrs until 17:30 hours on extension 4140, and during the out of hours session by bleep #6 555 2231."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 464,
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "A follow up phone call should be made to transfusion laboratory staff to advise them of the patient's details (where known) including:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 465,
            "data": {
                "is_heading": 0,
                "text": "First name, last name, date of birth, hospital number/unique number"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 466,
            "data": {
                "is_heading": 0,
                "text": "If a child: approximate weight."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 467,
            "data": {
                "is_heading": 0,
                "text": "Laboratory staff will provide a direct dial extension number so that follow up phone calls are made directly to the transfusion laboratory staff dealing with the Major Haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 468,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "The appropriate surgical expertise for the area of bleeding is crucial to the outcome   of the patient. There may be instances where the patient changes clinical teams and the appropriate staff member in contact with the Blood Transfusion Department can also change."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 469,
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "Inform the Blood Transfusion Department at the earliest opportunity so that the department can review the blood stock levels or re assign staff depending on the level of the haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 470,
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "Clearly identify who is receiving the information of the major haemorrhage in the Blood Transfusion Department and determine from them the length of time it will take to provide blood and blood products."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 471,
            "data": {
                "is_heading": 0,
                "prefix": 12.7,
                "text": "The Blood Transfusion Department will inform the contact person coordinating the incident as each of the MH packs leaves the department."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 472,
            "data": {
                "is_heading": 0,
                "prefix": 12.8,
                "text": "At the end of the emergency be sure to inform the Blood Transfusion Department"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 473,
            "data": {
                "is_heading": 0,
                "text": "that the case has been resolved. Laboratory staff can then stand down the MH, this   prevents blood products being wasted and allows staff to review stocks for"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 474,
            "data": {
                "is_heading": 0,
                "text": "replacement as required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 475,
            "data": {
                "is_heading": 0,
                "prefix": 12.9,
                "text": "Contact surgeons, gastroenterologists, or paediatrician as appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 476,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "The release of blood and blood components for initial resuscitation can be"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 477,
            "data": {
                "is_heading": 0,
                "text": "performed without the prior approval of a Consultant Haematologist. However,   consider involving the Consultant Haematologist on call for advice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 478,
            "data": {
                "is_heading": 0,
                "prefix": 12.11,
                "text": "Appropriate expertise for the site of bleeding is vital \u2013 vascular, general or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 479,
            "data": {
                "is_heading": 0,
                "text": "cardiothoracic surgeons, endoscopists or others with specific expertise may be   needed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 480,
            "data": {
                "is_heading": 0,
                "prefix": 12.12,
                "text": "Consideration should be given to early referral and, if necessary, transfer to other   centres to access such expertise. In the more difficult cases, early action may be   essential to pack visceral cavities, and cross clamping tying off major vessels"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 481,
            "data": {
                "is_heading": 0,
                "text": "may be required. Discussions for paediatric patients can be referred to Great"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 482,
            "data": {
                "is_heading": 0,
                "text": "Ormond Street Hospital for advice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 483,
            "data": {
                "is_heading": 0,
                "prefix": 12.13,
                "text": "An intensive care bed may be required and early communication is advisable to   ensure availability."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 484,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Transfusion guidelines should be adhered to at all times."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 485,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "The reason for transfusing each patient must be clearly documented in the patient's notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 486,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "All patients must wear an identification band (wristband) clearly showing the patients name, hospital number, gender and date of birth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 487,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "In the case of the emergency admission, where there is difficulty in positively"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 488,
            "data": {
                "is_heading": 0,
                "text": "identifying the patient, it is possible to use two points of identification on both the wristband and any samples collected for the first 24 hours or until positive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 489,
            "data": {
                "is_heading": 0,
                "text": "identification can be made. This must include the emergency admissions number"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 490,
            "data": {
                "is_heading": 0,
                "text": "and combination of first and surname from the phonetic alphabet e.g. Foxtrot Whisky or (as per the Trust identification policy MSEPO-21002."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 491,
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "The Blood Transfusion department will require a new sample and request form for record purposes once the patients' name, hospital number and date of birth are known. Care must be taken where there is more than one unknown patient as the emergency admission numbers are likely to be consecutive."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 492,
            "data": {
                "is_heading": 0,
                "prefix": 13.6,
                "text": "All staff involved in the transfusion pathway must complete mandatory training in blood transfusion and the training must be documented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 493,
            "data": {
                "is_heading": 0,
                "prefix": 13.7,
                "text": "Patients should be monitored during a transfusion according to the current guidelines. Some patients, such as those undergoing massive transfusion, may require more frequent monitoring due to their clinical condition."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 494,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "The main sources for danger which will lead to an adverse transfusion include but   are not limited to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 495,
            "data": {
                "is_heading": 0,
                "text": "Supplying the wrong sample to the laboratory for compatibility testing;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 496,
            "data": {
                "is_heading": 0,
                "text": "Failure to supply clinical information, particularly in regard to previous transfusions, pregnancies and blood grouping;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 497,
            "data": {
                "is_heading": 0,
                "text": "Use of a single common name (e.g. Smith) on forms and labels, leading to muddling of patients, specimens and blood units;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 498,
            "data": {
                "is_heading": 0,
                "text": "Error in laboratory cross-matching tests;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 499,
            "data": {
                "is_heading": 0,
                "text": "Mis-labelling of blood units;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 500,
            "data": {
                "is_heading": 0,
                "text": "Transfusing the wrong patient;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 501,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Leaving blood at room temperature before use, longer than the  minutes, thus encouraging bacterial growth;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 502,
            "data": {
                "is_heading": 0,
                "text": "Heating blood in hot water prior to transfusion or storing in non-approved blood banks causing cell disintegration."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 503,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "All adverse transfusion reactions and events must be reported to the Blood Transfusion Department via a Transfusion Reaction form and Datix. The Blood Transfusion Department will report to MHRA via Serious Adverse Blood Reactions and Events (SABRE) and Serious Hazards of Transfusion (SHOT) if appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 504,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Tranexamic acid (adult 0.5-1g, children 15mg/kg bolus up to a maximum of 1g) IV   has a role in reducing bleeding enhanced by fibrinolysis as in cases of uro-genital   tract bleeding. It is contra-indicated in cases of Disseminated Intravascular   Coagulation (DIC)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 505,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "In high\u2010risk surgery, tranexamic acid at a dose of  mg/kg followed by 1 mg/kg/h is   recommended to prevent bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 506,
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Etamsylate (Dicynene) can reduce capillary bleeding in the presence of a normal number of platelets correcting abnormal adhesion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 507,
            "data": {
                "is_heading": 0,
                "prefix": 15.4,
                "text": "Unexplained bleeding could be caused by drugs such as clopidogrel, aspirin and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 508,
            "data": {
                "is_heading": 0,
                "text": "anti-coagulants. Detailed history of patients' drug therapy should be documented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 509,
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Criteria for use of Recombinant Factor VIIa (NovoSeven) may include severe"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 510,
            "data": {
                "is_heading": 0,
                "text": "haemorrhage where there is reasonable prospect of long term recovery \u2013 multiple   trauma."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 511,
            "data": {
                "is_heading": 0,
                "prefix": 15.6,
                "text": "Adult trauma patients with, or at risk of, major haemorrhage, in whom"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 512,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "antifibrinolytics are not contraindicated, should be given tranexamic acid as soon   as possible after injury, at a dose of 1 g intravenously over  min followed by a   maintenance infusion of 1 g over 8 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 513,
            "data": {
                "is_heading": 0,
                "prefix": 15.7,
                "text": "The use of tranexamic acid should be considered in non\u2010traumatic major bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 514,
            "data": {
                "is_heading": 0,
                "prefix": 15.8,
                "text": "The routine use of aprotinin is not recommended."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 515,
            "data": {
                "is_heading": 0,
                "prefix": 15.9,
                "text": "Patients with inherited bleeding disorders should be managed in collaboration with"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 516,
            "data": {
                "is_heading": 0,
                "text": "the local Haemophilia Centre, and bleeding in patients receiving antiplatelet"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 517,
            "data": {
                "is_heading": 0,
                "text": "medication and/or anticoagulants should be managed according to appropriate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 518,
            "data": {
                "is_heading": 0,
                "text": "British Standards of Haematology (BSH) guidelines."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 519,
            "data": {
                "is_heading": 1,
                "text": "Stop the bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 520,
            "data": {
                "is_heading": 0,
                "text": "Guidelines differ for adults and children;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 521,
            "data": {
                "is_heading": 0,
                "text": "Refer to appendix 2 and 3 \u2013 Guidelines on the management of adult Major Haemorrhage;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 522,
            "data": {
                "is_heading": 0,
                "text": "Refer to Appendix 4 for East of England Children Major Haemorrhage in children protocol;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 523,
            "data": {
                "is_heading": 0,
                "text": "Summon senior help;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 524,
            "data": {
                "is_heading": 0,
                "text": "Activate the Major Haemorrhage protocol and inform a senior member of Blood Transfusion Department or on call laboratory staff of urgency of request. Inform other departments within Pathology as required. If required seek the advice of the Consultant Haematologist on call;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 525,
            "data": {
                "is_heading": 0,
                "text": "Give oxygen;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 526,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Establish a minimum oflarge bore I.V. access points (or as large as possible)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 527,
            "data": {
                "is_heading": 1,
                "text": "During insertion, draw blood samples for cross-match, correctly label the sample and request form, and dispatch immediately to the laboratory DO NOT SEND VIA THE POD SYSTEM - DELIVER BY HAND DIRECTLY TO A MEMBER OF STAFF IN THE BLOOD TRANSFUSION DEPARTMENT;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 528,
            "data": {
                "is_heading": 0,
                "text": "Infuse 1 to 2 litres (or if a child 10-20ml/kg) of crystalloid or colloid In Trauma patients resuscitate to a central pulse with blood products in 1:1:1 ratio as soon as possible. Consider use of 250mls boluses (10-20 mls / kg in children) of warmed crystalloid until blood is available. Control haemorrhage as soon as possible;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 529,
            "data": {
                "is_heading": 0,
                "text": "Assess the response to the fluid challenge and repeat if necessary. Decide at this stage whether you require type specific blood or fully cross-matched blood;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 530,
            "data": {
                "is_heading": 0,
                "text": "Commence Pack One (primary pack). The transfusion should be given through a fluid/blood warmer. If the patient is a child, the volume of blood product will depend on the child's weight see appendix 4;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 531,
            "data": {
                "is_heading": 0,
                "text": "Do not wait for blood results before transfusing blood;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 532,
            "data": {
                "is_heading": 0,
                "text": "Consider the use of cell salvage to reduce requirement for banked blood;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 533,
            "data": {
                "is_heading": 0,
                "text": "Consider the use of Prothrombin Complex Concentrate (PCC);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 534,
            "data": {
                "is_heading": 0,
                "text": "Consider the use of clotting factor concentrates (factor VIIa);"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 535,
            "data": {
                "is_heading": 0,
                "text": "If you are unable to maintain blood pressure and pulse in the face of massive transfusion, consider emergency surgery or interventional radiology;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 536,
            "data": {
                "is_heading": 0,
                "text": "Prevent core cooling;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 537,
            "data": {
                "is_heading": 0,
                "text": "Coagulation screen and platelet count with supplementation of the required elements on the basis of the results and in consultation with the Consultant Haematologist;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 538,
            "data": {
                "is_heading": 0,
                "text": "Consider tranexamic acid."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 539,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Training Requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 540,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "All staff, appropriate to their grade and training needs analysis, must attend the Risk Management Clinical day training sessions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 541,
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "All staff must undertake the required assessments, as identified in the training needs analysis, developed by the National Patients Safety Agency to undertake the task that is required to be performed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 542,
            "data": {
                "is_heading": 0,
                "prefix": 17.3,
                "text": "Nursing staff who satisfy the Nursing Midwifery Council (NMC) requirements, may collect, label and sign samples for group and cross-matching purposes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 543,
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "The clinician in charge of the case will designate the appropriate staff member to be able to co-ordinate the line of communication between the Blood Transfusion Department and the clinical team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 544,
            "data": {
                "is_heading": 0,
                "prefix": 17.5,
                "text": "All staff who:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 545,
            "data": {
                "is_heading": 0,
                "text": "Collect a venous sample of blood for blood transfusion testing;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 546,
            "data": {
                "is_heading": 0,
                "text": "Collect blood and blood products from the blood bank;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 547,
            "data": {
                "is_heading": 0,
                "text": "Organise the receipt of blood and blood products;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 548,
            "data": {
                "is_heading": 0,
                "text": "Prepare to administer and administer blood and blood products to patients will undergo training and be assessed by observation of competencies as developed by the National Patients Safety Agency (NPSA)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 549,
            "data": {
                "is_heading": 0,
                "prefix": 17.6,
                "text": "Refer to the policy 04184 Manual of Blood Transfusion Policy and Procedures for the competencies to be assessed."
            }
        },
        {
            "type": "table",
            "sequence_num": 550,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 551,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "monitored"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "monitoring"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "actions are completed"
                    },
                    {
                        "text": "Activation and management of MHP"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "HTT"
                    },
                    {
                        "text": "Annually"
                    },
                    {
                        "text": "Hospital Transfusion Group (HTG)"
                    },
                    {
                        "text": "Patient Safety Group"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 552,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "The Trust will work towards effective governance and monitoring of the policy by   regular audits against the policy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 553,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "The Blood Transfusion Department will take part in all relevant National Blood   and Transplant National Audits to monitor and assess the Trust's performance   nationally against the procedures in the transfusion policy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 554,
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "Findings from all National Audits organised by the National Blood Transfusion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 555,
            "data": {
                "is_heading": 0,
                "text": "Blood and Transplant Service will be reported to the Hospital Transfusion Group   meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 556,
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "The findings will be reported to the Transfusion Group and this group will monitor   implementation of any organisational actions developed to address any"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 557,
            "data": {
                "is_heading": 0,
                "text": "deficiencies. The Chair of the group will be responsible for ensuring actions are"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 558,
            "data": {
                "is_heading": 0,
                "text": "progressed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 559,
            "data": {
                "is_heading": 0,
                "prefix": 18.5,
                "text": "The findings will be reported to appropriate divisional / directorate governance   meetings and clinical leads will be responsible for developing local actions to   address any non-compliance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 560,
            "data": {
                "is_heading": 0,
                "prefix": 18.6,
                "text": "The Blood Transfusion Department will submit quality data as and when required   to be submitted to the Trauma and Audit Research Network."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 561,
            "data": {
                "is_heading": 0,
                "prefix": 18.7,
                "text": "In addition monthly patient identification and observation snap shot audits of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 562,
            "data": {
                "is_heading": 0,
                "text": "patient are undertaken by the Transfusion Nurse Practitioner such that all high risk   areas are assessed on a rolling programme. The findings of these audits are fed"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 563,
            "data": {
                "is_heading": 0,
                "text": "back to local line managers for action as required. The findings will also be reported   to Divisional Governance Meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 564,
            "data": {
                "is_heading": 0,
                "prefix": 18.8,
                "text": "In the event that any part of the policy is not followed a Datix will be raised and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 565,
            "data": {
                "is_heading": 0,
                "text": "reviewed by the Hospital Transfusion Team, the Hospital Transfusion Group and   appropriate clinical speciality."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 566,
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "The approval of this policy will be undertaken by members of the Hospital"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 567,
            "data": {
                "is_heading": 0,
                "text": "Transfusion Group, Hospital Trauma Group, Paediatric, Surgical and Medical   representatives."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 568,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "The Hospital Transfusion Group will inform Maternity representatives of changes to   the policy so that any amendments can be made to Maternity's policies 04234"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 569,
            "data": {
                "is_heading": 0,
                "text": "Management of postpartum haemorrhage, and 07024 Transport of Blood, Blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 570,
            "data": {
                "is_heading": 0,
                "text": "Products in an Obstetric Emergency."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 571,
            "data": {
                "is_heading": 0,
                "prefix": 65.0,
                "text": "B.M.A. September 1994, Intravenous Additives (Appendix 4). British National Formulary No.  London British Medical Association and the Royal Pharmaceutical Society of Great Britain 999-1008."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 572,
            "data": {
                "is_heading": 0,
                "text": "Bradbury M., Cruickshank J.P. 1995. Blood and Blood Transfusion Reactions: 1 British Journal of Nursing 4 (14): pp814 \u2013 817"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 573,
            "data": {
                "is_heading": 0,
                "text": "Bradbury M., Cruickshank J.P. 1995. Blood and Blood Transfusion Reactions: 2 British Journal of Nursing 4 (15): pp861 - 868."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 574,
            "data": {
                "is_heading": 0,
                "text": "Bradbury M., Cruickshank J.P., 2000. Blood transfusion: crucial steps in maintaining safe practice. British Journal of Nursing, 9 (3), pp134 - 138."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 575,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2016).Transfusion for foetuses, neonates and older children. London:British Society for Haematology. Available at: https://b-s- h.org.uk/guidelines/guidelines/transfusion-for -fetuses-neonates-and-older-children"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 576,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2012). Pre-transfusion compatibility procedures in blood transfusion laboratories. London:British Society for Haematology. Available at: https://b-s-h.org.uk/guidelines/guidelines/pre-transfusion-compatibility-procedures- in-blood-transfusion-laboratories"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 577,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2012). Management of anaemia and red cell transfusion in adult critically ill patients. London:British Society for Haematology. Available at: https://b-s-h.org.uk/guidelines/guidelines/management-of-anaemia- and-red-cell-transfusion-in-adult-critically-ill-patients/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 578,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2018)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 579,
            "data": {
                "is_heading": 0,
                "text": "Spectrum of fresh frozen plasma and Cryoprecipitate products. Available at: https://b-s-h.org.uk/guidelines/guidelines/spectrum-of-fresh-frozen-plasma-and- cryoprecipitate-products/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 580,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2016). Use of platelet transfusions. Available at: https://b-s-h.org.uk/guidelines/guidelines/use-of-platelet-transfusions/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 581,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2012). Investigation and management of acute transfusion reactions. Available at: https://b-s-h.org.uk/guidelines/guidelines/investigation-and-management-of-acute- transfusion-reactions/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 582,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2017). Administration of blood components. Available at https://b-s-h.org.uk/guidelines/guidelines/administration-of-blood- components/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 583,
            "data": {
                "is_heading": 0,
                "text": "British Society for Haematology, (2015). Haematological management of major haemorrhage. Available at: https://b-s-.org.uk/guidelines/guidelines/haematological- management-of-major-haemorrhage/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 584,
            "data": {
                "is_heading": 0,
                "text": "The CRASH-2 collaborators et al, 2011. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH- 2 randomised controlled trial. Lancet, 377(9771), pp1096-1101."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 585,
            "data": {
                "is_heading": 0,
                "text": "Directive 2002/98/EC of the European Parliament and of the Council. Available at: https://eur-lex.europa.eu/legal-ontent/EN/TXT/?qid=1579878126486&uri= CELEX:32002L0098"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 586,
            "data": {
                "is_heading": 0,
                "text": "The Blood Safety and Quality Regulations 2005 amendment 2006/2013. Available at: http://www.legislation.gov.uk/uksi/2005/50/contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 587,
            "data": {
                "is_heading": 0,
                "text": "East of England Regional Transfusion Committee, 2017. Major haemorrhage EoE guideline. Available at: https://www.transfusionguidelines.org/uk-transfusion- committees/regional-transfusion-committees/east-of-england/policies"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 588,
            "data": {
                "is_heading": 0,
                "text": "Chapman, J.F. et al, 2004. Guidelines for compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 14(1), pp59-73."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 589,
            "data": {
                "is_heading": 0,
                "text": "O'Shaughnessy, D.F. et al, 2004 Guidelines for the use of fresh-frozen plasma,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 590,
            "data": {
                "is_heading": 0,
                "prefix": 28.0,
                "text": "cryoprecipitate and cryosupernatant. British Journal of Haematology, 126(1) pp11-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 591,
            "data": {
                "is_heading": 0,
                "text": "Murphy, M. F. et al, 2001. Guidelines for the clinical use of red cell transfusions. British Journal of Haematology, 113(1), pp24-31."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 592,
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "NICE Guidelines NG 39. Major Trauma: Assessment and Initial Management Norfolk, Dr Derek (ed), 2013. Handbook of transfusion medicine. th ed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 593,
            "data": {
                "is_heading": 0,
                "text": "London:HMSO. Available via the Warner Library"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 594,
            "data": {
                "is_heading": 0,
                "text": "NPSA/2010/RRR017 The Transfusion of Blood and Blood Components in an Emergency"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 595,
            "data": {
                "is_heading": 0,
                "text": "Nursing & Midwifery Council, 2009. Record keeping: guidance for nurses and midwives. London:Nursing &Midwifery Council. Available at: https://www.nmc.org.uk/standards/code/record-keeping/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 596,
            "data": {
                "is_heading": 0,
                "text": "Nursing & Midwifery Council, 2008. The Code: professional standards of practice and behaviour for nurses, midwives and nursing associates. London: Nursing & Midwifery Council. Available at: https://www.nmc.org.uk/standards/code"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 597,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Nursing, 2013. Right blood, right patient, right time: RCN guidance"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 598,
            "data": {
                "is_heading": 0,
                "text": "The Clinical Use of Blood Handbook, World Health Organisation, Blood Transfusion Safety. WHO, Geneva, 2003."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 599,
            "data": {
                "is_heading": 0,
                "text": "Serious Hazards of Transfusion. SHOT annual report and summary. Available at: https://www.shotuk.org/ \u2013 click Annual Reports & Summaries tab for latest edition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 600,
            "data": {
                "is_heading": 0,
                "text": "World Health Organization,(2002).The Clinical Use of Blood Handbook. Geneva: World Health Organisation. Available at: https://www.who.int/bloodsafety/clinical_use/en/  Related documents \u201cThe clinical use of blood (handbook)\u201d English 717kb"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 601,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 4)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 602,
            "data": {
                "is_heading": 0,
                "text": "Major Haemorrhage Management / 13012 / 3.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 603,
            "data": {
                "is_heading": 1,
                "prefix": 39.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 604,
            "data": {
                "is_heading": 0,
                "text": "Appendix 1"
            }
        },
        {
            "type": "image",
            "sequence_num": 605,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.001.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 606,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.002.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 607,
            "data": {
                "is_heading": 0,
                "text": "Appendix 2"
            }
        },
        {
            "type": "image",
            "sequence_num": 608,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 609,
            "data": {
                "is_heading": 0,
                "text": "Appendix 3"
            }
        },
        {
            "type": "image",
            "sequence_num": 610,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.004.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 611,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.005.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 612,
            "data": {
                "is_heading": 0,
                "text": "Major Haemorrhage Management / 13012 / 3.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 613,
            "data": {
                "is_heading": 1,
                "prefix": 39.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 614,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Appendix: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 615,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Major Haemorrhage Management 13012: (Please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 616,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 617,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Update into MSE Trust format, Mid Essex retains MHP for site"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Three hospitals have merged into one Trust"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Trust"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Dr Niven Akotia HTG lead, Dr Waseem Nagi, Consultant Anaesthetist with responsibility for Transfusion, Dr Alex Hieatt Trauma Lead, Dr Klewe Consultant in Emergency Medicine"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 618,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Transfusion Practitioner"
                    },
                    {
                        "text": "03 August 2021"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 619,
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            }
        },
        {
            "type": "image",
            "sequence_num": 620,
            "data": {
                "url": "13012 Major Haemorrhage Management 3.1.002.png"
            }
        }
    ]
}